Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA COLLECTING VOLUNTARY INDUSTRY COMPLIANCE DATA

This article was originally published in The Tan Sheet

Executive Summary

FDA COLLECTING VOLUNTARY INDUSTRY COMPLIANCE DATA that will be used as another measure of the agency's enforcement activities along with approval, disapproval and enforcement information, Office of Enforcement Director Daniel Michels told the Food & Drug Law Institute annual meeting Dec. 14. "We think it is one of the best measures of success on both sides," Michels said. In the future, "we can collectively take pride in the reality that a violative situation was corrected without having to go to a formal enforcement action."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel